Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Platelet aggregation during adjuvant chemotherapy with CMF].

G Sbalzarini1, C Pandolfi, A Labadini

  • 1I Divisione Medica, USSL n. 56, Ospedale Maggiore di Lodi.

Minerva Medica
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extrafloral-nectar-based partner manipulation in plant-ant relationships.

AoB PLANTS·2015
Same author

A novel technique to close large perforation of sinus membrane.

ORAL & implantology·2013
Same author

Four impacted fourth molars in a young patient: a case report.

ORAL & implantology·2013
Same author

Maxillary cyst: description of a clinical case.

ORAL & implantology·2013
Same author

Primary lymphoma of the liver - a case-report and a review of the literature.

Oncology reports·2011
Same author

In-patient rehabilitation in haemophilic subjects with total knee arthroplasty.

Haemophilia : the official journal of the World Federation of Hemophilia·2011

Cyclical adjuvant chemotherapy (CMF) did not alter platelet aggregation in women with breast cancer. This finding applies to both pre- and post-menopausal patients undergoing treatment for mammary cancer.

Area of Science:

  • Oncology
  • Hematology
  • Pharmacology

Background:

  • Breast cancer treatment often involves chemotherapy.
  • Cyclical adjuvant CMF chemotherapy is a common regimen for mammary cancer.
  • Platelet aggregation is a critical hemostatic process that can be affected by cancer therapies.

Purpose of the Study:

  • To investigate the impact of cyclical adjuvant CMF chemotherapy on platelet aggregation.
  • To assess chemotherapy's effect on platelet function in breast cancer patients.

Main Methods:

  • Studied platelet aggregation in fourteen pre- and post-menopausal women.
  • Patients had previously undergone surgery for mammary cancer with positive axillary nodes.
  • Cyclical adjuvant CMF chemotherapy was administered.

Related Experiment Videos

Main Results:

  • Cyclical adjuvant CMF chemotherapy did not significantly modify platelet aggregation.
  • No difference in effect was observed between pre- and post-menopausal patients.

Conclusions:

  • CMF chemotherapy does not appear to affect platelet aggregation in breast cancer patients.
  • Platelet function remains stable during CMF treatment regardless of menopausal status.